Search
Total Count 252

SPIMACO - Latest News

SPIMACO to launch new products, expand in Africa, Europe: Vice Chairman

Argaam 07/09/2025

SPIMACO CEO contract ends; Ahmed Aljedai to stay in charge

Argaam 28/08/2025

SPIMACO updates 2025 guidance

Argaam Special 13/08/2025

SPIMACO CFO says private sector, expansions to drive Q3 growth

Argaam 05/08/2025

SPIMACO inaugurates oncology, high-potent drug plant

Argaam 27/07/2025

Morgan Stanley 'market maker' for 40 TASI, Nomu firms

Argaam 14/07/2025

United Securities issues Q2 2025 earnings forecast

Argaam 06/07/2025

Al Rajhi Capital issues earnings estimates for Q2 2025

Argaam 03/07/2025

SPIMACO shareholders OK dividend freeze for 2024

Argaam 30/06/2025

SPIMACO updates 2025 guidance

Argaam Special 28/05/2025

SPIMACO's market share hits 12.1%, positive performance to sustain: CFO

Argaam Special 15/05/2025

Al Rajhi Capital issues Q1 2025 profit forecasts for TASI-listed firms

Argaam 14/04/2025

SPIMACO appoints Khalid Al-Gwaiz as Chairman, Ahmed Aljedai as Vice Chairman

Argaam 08/04/2025

SPIMACO board proposes dividend freeze for 2024

Argaam 27/03/2025

SPIMACO signs deal with China’s CNBG to supply, manufacture vaccines

Argaam 27/03/2025

SPIMACO signs agreement with CanSinoBIO to supply vaccines

Argaam 26/03/2025

SPIMACO elects board members for upcoming term

Argaam 27/02/2025

What do analysts expect from SPIMACO’s Q4 2024 results?

Argaam Special 17/02/2025

SPIMACO CEO agrees to retain post for 6 additional months

Argaam 12/02/2025

SPIMACO shareholders to elect board members on Feb. 26

Argaam 29/01/2025

SPIMACO inks sale, distribution contract for SAR 164.1M annually

ِArgaam 19/01/2025

United Securities issues Q4 2024 earnings forecasts

Argaam 09/01/2025

Al Rajhi Capital issues Q4 2024 profit forecasts for TASI-listed firms

Argaam Special 02/01/2025

SPIMACO obtains SAR 220M credit facilities from Alinma Bank

Argaam 25/12/2024

Alawwal Capital initiates coverage on SPIMACO

Argaam 24/12/2024

SPIMACO reviews 2024 guidance

Argaam Special 23/12/2024

SPIMACO says deal to buy 68% of Osmopharm, exit SPIMACO Misr scrapped

ِArgaam 04/12/2024

United Securities says SPIMACO’s Q3 2024 topline below estimate, lowers TP

Argaam 24/11/2024

SPIMACO approves CEO request not to renew contract

Argaam 24/11/2024

SPIMACO extends deadline to buy 68% of Osmopharm, exit SPIMACO Misr

Argaam 14/11/2024

Analyst forecasts for SPIMACO's Q3 2024 financials

Argaam Special 31/10/2024

Al Rajhi Capital issues Q3 2024 earnings forecasts for more Tadawul-listed firms

Argaam 07/10/2024

United Securities: As earnings loom, what to expect in Q3 2024?

Argaam 06/10/2024

Saudi pharmaceuticals sector seen to grow: Al Rajhi Capital

ِArgaam 09/09/2024

Board member, senior exec ownership changes in Tadawul on Aug. 28

Argaam Special 02/09/2024

United Securities assigns rating, TP for SPIMACO

Argaam 21/08/2024

SPIMACO holds 6% of market, seeks 12% revenue growth

Argaam Special 19/08/2024

SPIMACO, Altos Biologics sign deal to produce, market ALT-L9 in 16 key markets

Argaam 31/07/2024

What analysts expect from SPIMACO Q2 2024 results?

Argaam Special 28/07/2024

United Securities issues Q2 earnings estimates

Argaam 16/07/2024

Al Rajhi Capital issues Q2 2024 profit forecasts

Argaam 04/07/2024

SPIMACO plans to appoint new external auditor

Argaam 13/06/2024

SPIMACO net profit expected to rise in Q1 2024

Argaam Special 08/05/2024

SPIMACO committed to expansion of complex products, focuses on African markets: CEO

Argaam 21/04/2024

Senior execs of Aramco, SNB, eXtra, stc highest paid in 2023

Argaam Special 21/04/2024

Highest-paid executives, board members of Saudi-listed firms in 2023

Argaam Special 16/04/2024

Al Rajhi Capital issues Q1 profit forecasts for TASI-listed firms

Argaam 06/04/2024

SPIMACO continues deleveraging with robust financial position: CEO

Argaam 04/04/2024

SPIMACO board proposes to withhold 2023 dividends

Argaam 31/03/2024

SPIMACO appoints Jérôme Cabannes as CEO

Argaam 21/02/2024